Breaking News

BMS To Expand R&D in India

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb has plans to expand its R&D capabilities in India in collaboration with Biocon Ltd. and Accenture Ltd. According to a company statement, BMS will work with Biocon, India’s largest biotechnology firm, to set up a research facility in Bangalore to help its discovery and early drug development. The Bangalore facility will have the potential to accommodate more than 400 scientists. BMS also entered a multi-year agreement with Accenture, a consulting firm, to inclu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters